mTOR signaling pathway and mTOR inhibitors in cancer: progress and challengesZhilin Zou(Guangdong Medical College), Xiao Zhu(Guangdong Medical College)Cell & BioscienceMarch 10, 202010.1186/s13578-020-00396-1Cited by 935SaveCiteExport RISWatch citationsRelated Papersp53 inhibits the expression of p125 and the methylation of POLD1 gene promoter by downregulating the Sp1-induced DNMT1 activities in breast cancer|OncoTargets and Therapy|2016|25